H. Courtney Hodges
@hodgeshc.bsky.social
340 followers 220 following 12 posts
Baylor College of Medicine
Posts Media Videos Starter Packs
Pinned
hodgeshc.bsky.social
How do chromatin remodelers use #IDRs to find TF binding partners? In our new Molecular Cell paper, we show that β-catenin is an adaptor that links SWI/SNF (cBAF) subunit ARID1A with binding partners via IDR-domain interactions.
www.cell.com/molecular-ce...
hodgeshc.bsky.social
Thanks a lot Ariel. We hope it may increase focus on IDR-domain interactions, we think there’s a lot to do in that space. Hope you’re doing great!
hodgeshc.bsky.social
We were very lucky to have so many amazing collaborators on this paper, including @vaclav-veverka.bsky.social, @cermakova.bsky.social, and many others, including Yuen San Chan as first author. Please check out our paper for more information!
hodgeshc.bsky.social
Excitingly, β-catenin links cBAF not only to SF-1, but also to YAP1, SOX2, FOXO3, and CBP/p300, highlighting its critical role in chromatin remodeling across diverse cellular processes
hodgeshc.bsky.social
Dissection of interactions revealed that intrinsically disordered regions (IDRs) of ARID1A bind directly to the structured Armadillo domain of β-catenin
hodgeshc.bsky.social
Sustained inhibition leads to loss of steroid production, positioning cBAF as a key steroidogenic dependency
hodgeshc.bsky.social
We show that BAF inhibition disrupts the ability of the TF known as steroidogenic factor 1 (SF-1) and β-catenin to bind at enhancers targeted by ARID1A
hodgeshc.bsky.social
How do chromatin remodelers use #IDRs to find TF binding partners? In our new Molecular Cell paper, we show that β-catenin is an adaptor that links SWI/SNF (cBAF) subunit ARID1A with binding partners via IDR-domain interactions.
www.cell.com/molecular-ce...
hodgeshc.bsky.social
We also show that neural crest cells and NCC-derived neurons tolerate SWI/SNF inhibition. I anticipate that non-cycling cells are frequently independent, and cycling cells with different circuitries have alternatives or plasticity to activate Cyclin D
hodgeshc.bsky.social
Thanks Hiten, it is surprising that SWI/SNF inhibition is well tolerated, and we've seen very good therapeutic window in vivo. Not all cycling cells need SWI/SNF, it's dispensable for example in HEK293Ts
hodgeshc.bsky.social
What do SWI/SNF-addicted cancers have in common? And when are they most sensitive to SWI/SNF inhibition? Check out Katka’s thread highlighting our most recent paper
cermakova.bsky.social
For the first time, we find a common mechanism for SWI/SNF addiction in cancer! Our paper reveals that G1 phase is a critical junction for SWI/SNF activity in several addicted cancers, including neuroblastoma, AML, prostate cancer, and uveal melanoma academic.oup.com/nar/advance-... (1/6)
Reposted by H. Courtney Hodges
alexholehouse.bsky.social
A labor of love - our review on why IDRs matter for cellular function is live in Nat. Rev. Mol. Cell. Biol:
www.nature.com/articles/s41...

Working with Birthe Kraglund on this was such a pleasure, and we hope this review will be helpful to a broad audience!